Tex Peptides: the retatrutide page the FDA quoted, still selling three months after the letter
texpeptide.comscored on 9 of 12 criteria · 3 could not be told
Be the first. The form below takes about twenty seconds and needs no account.
The score above weighs both: ours is what the record shows, theirs is what people who dealt with this entity say.
-
Is there an identifiable legal operator: a registered name, a jurisdiction, an address that resolves?
the site names its company, TXP Innovations LLC, and Texas records an active LLC of that name; the only addresses are a PO box in Orange on the site and a private mailbox in Dallas on the state record and the FDA letter
-
Does it publish third-party certificates of analysis for what it sells?
six lot-numbered reports from one lab, Chromate, all from September 2025, for four of 34 products; none for semaglutide, SS-31, tesamorelin or PT-141; the About page promises lab reports for every product; HPLC with UV only; the lab's site claims no accreditation
-
No disease claims, no 'safe', no borrowed botanical names for synthetic compounds?
in July 2026 the FDA quoted weight-loss, diabetes and libido claims from six product pages; by September the pages said only that the product arrives as a powder; a reconstitution solvent is still sold beside the peptides
-
Pattern of complaints about orders not arriving, long delays, no tracking?
no thread found in five subreddits' archives
Evidence: [17]
-
Pattern of complaints about wrong, inert, contaminated or mislabelled product?
no buyer report found; the store's certificates are its own and are covered under lab results
Evidence: [17]
-
Chargebacks refused, refunds unanswered, processors dropped?
no payment or refund policy in the archived pages
- Operating since
- at least 2025-08-11 (the domain was registered 2025-08-11 and the LLC chartered in Texas the next day; the oldest certificate was produced 2025-09-16; the first archived copy of the site is 2026-09-20)
- Where
- a post-office box in Orange, Texas (the contact page, archived September 2026); a private mailbox at 539 W Commerce St, Dallas, Texas (the Texas Comptroller's franchise-tax record; the FDA letter gives the same street address)
- Presence
- @texpeptides @texpeptides
- Verified
- every quotation checked against its document on 2026-11-18; 27 sources
What they sell, and what we think is in it
- GLP-3 RT (10mg, 20mg) Peptides
Product will arrive in a lyophilized (powder) form for maximum stability
Retatrutide - GLP-2 TRZ (15mg, 30mg) Peptides
GLP-2 TRZ (30mg)
Tirzepatide - GLP-1 SEM (10mg, 20mg) Peptides
GLP-1 SEM (10mg)
Semaglutide - SS-31 (10mg) Peptides
SS-31 (10mg)
elamipretide, a mitochondria-targeted peptide; named in the FDA letter - Tesamorelin (10mg) Peptides
Tesamorelin (10mg)
tesamorelin, a growth-hormone-releasing hormone analogue sold as a prescription drug; named in the FDA letter - PT-141 (10MG) Peptides
PT-141 (10MG)
bremelanotide, a melanocortin agonist approved as a prescription drug; named in the FDA letter - BPC-157, vials, tablets and blends (Wolverine, GLOW, KLOW) Peptides
BPC-157- (500mcg) 30 Tablets
BPC-157 with TB-500, GHK-Cu and KPV in the blends - Semax (10mg), Selank (10mg) Nootropics
Semax (10mg)
SemaxSelank - Melanotan II, MOTS-C, NAD+ and other research peptides Peptides
Melanotan II (10mg)
melanotan II, MOTS-C, NAD+, ipamorelin, AOD-9604 and others; no page here - Acetic Water 0.6% Acetic Acid (3ml) Other
Acetic Water 0.6% Acetic Acid (3ml)
a solvent for dissolving the powders, listed under Reconstitution Solutions
Molecules named in this dossier
- BPC-157 sells
- Retatrutide sells
- Selank sells
- Semaglutide sells
- Semax sells
- Tirzepatide sells
Pulse what people say about Tex Peptides
One tap, no account. Then for up to 36 Methyls.
The long read
Who they say they are, and what the record says
Tex Peptides sells peptides from a website at texpeptide.com. The site calls itself "a trusted Texas based supplier of premium research compounds"[1] and "a Texas-based company".[2] Its contact page names the company behind it, "TXP Innovations LLC PO BOX 108", "Orange, Tx 77631", and gives a phone number with a southeast Texas area code, "+1-409-289-4224".[3] It links to Instagram and TikTok accounts named @texpeptides.[3]
The state's records agree on the name and give a second address. The Texas Comptroller lists "TXP INNOVATIONS LLC" as an active Texas limited liability company, Secretary of State file "0806166600", chartered on "2025-08-12". Its address on that record is "539 W COMMERCE ST PMB 8220" in Dallas.[4] A PMB is a private mailbox. The domain texpeptide.com was registered on 11 August 2025, the day before the company was chartered.[5] The FDA addressed its letter to "TXP Innovations LLC dba Tex Peptides" at "539 West Commerce Street", the same Dallas street address, and named its chief executive.[6]
So the operator has a registered name and a jurisdiction, and both addresses on record are mail drops: a post-office box in Orange, about 280 miles east of Dallas, on the site, and a private mailbox in Dallas on the state's record. We found no street address for premises.
Not Texas Peptides Inc. Eli Lilly sued a different company with a similar name. Lilly's defendant, Texas Peptides Inc., "is a Wyoming corporation with its principal place of business at 30 N. Gould Street" in Sheridan, Wyoming, and it "operates a website at texaspeptidesinc.com".[7] Lilly dismissed that case with prejudice on 15 October 2026.[8] Nothing we found connects the two companies. This dossier is about TXP Innovations LLC and texpeptide.com only. The tracker of Lilly's suits covers the other one.
How long. The domain dates from August 2025 and the oldest laboratory report the store publishes was produced in September 2025.[5][9] The Wayback Machine holds no copy of the site before 20 September 2026, a month after the FDA's letter. What the site said before that comes from the letter.
What they sell
The September 2026 catalogue lists 34 items: research peptides, blends such as "Wolverine Blend", tablets such as "BPC-157- (500mcg) 30 Tablets", and one solvent, "Acetic Water 0.6% Acetic Acid (3ml)", under a heading "Reconstitution Solutions".[10] The home page promises "99% Purity, American Lab tested".[1]
Code names. The three weight-loss drugs are sold under codes. Retatrutide, Eli Lilly's investigational triple agonist, which no regulator has approved, is "GLP-3 RT (10mg)" and "GLP-3 RT (20mg)". Tirzepatide, the active ingredient of Lilly's Mounjaro and Zepbound, is "GLP-2 TRZ (15mg)" and "GLP-2 TRZ (30mg)". Semaglutide, the active ingredient of Novo Nordisk's Ozempic and Wegovy, is "GLP-1 SEM (10mg)" and "GLP-1 SEM (20mg)".[10] The FDA's letter decodes them: "Retatrutide (GLP-3 RT)", "Tirzepatide (GLP-2 TRZ)", "Semaglutide (GLP-1 SEM)".[6] The vial in the retatrutide photo is labelled RETATRUTIDE.[11]

Figure 1. The page the FDA quoted, on 18 November 2026, nearly three months after the letter: GLP-3 RT (20mg), $200, in stock. The name is a code; the vial in the photo says RETATRUTIDE.[11]
The catalogue also lists "SS-31 (10mg)", "Tesamorelin (10mg)" and "PT-141 (10MG)", the other three peptides the FDA named,[10] and "Melanotan II (10mg)", "MOTS-C (10mg)", "Semax (10mg)" and "Selank (10mg)".[10]
The wrong molecule on the retatrutide page. Each product page has a "Chemical profile" table. The 20 mg retatrutide page gives "Molecular formula: C62H98N16O22", synonyms "Bepecin, PLD-116", the sequence "GEPPPGKPADDAGLV" and the CAS number "37525-51-0".[12] Those are BPC-157's formula, synonyms and sequence: PubChem lists BPC-157 as C62H98N16O22, 1419.5 g/mol, with the synonyms Bepecin and PLD-116 and CAS number 137525-51-0, of which the site's number drops the first digit.[13] Retatrutide is a 39-amino-acid peptide; the sequence on the page has 15. The 10 mg retatrutide page carries the same table.[14] The semaglutide and tirzepatide pages give formulas of their own, "C187H291N45O59" and "C225H348N48O68".[15][16] The table was still on the 20 mg page on 18 November.[11]

Figure 2. The chemical profile on the retatrutide page is BPC-157's: its formula, its weight, its synonyms Bepecin and PLD-116, and its 15-amino-acid sequence. Retatrutide is a 39-amino-acid peptide.[11]
What buyers report
On 18 November 2026 we searched the Arctic Shift archives of r/Peptides (18,427 posts since 1 September 2025), r/Retatrutide (20,000 posts since 7 June 2026), r/moreplatesmoredates, r/sarmssourcetalk and r/fitness for "Tex Peptides", "texpeptide", "TXP" and "Texas peptides". No thread names the store.[17] We have no buyer's account of an order, good or bad. The home page carries four short testimonials, each signed with a name and the title "Independent Researcher".[1] None can be traced to a buyer.
Lab results
The store's certificates page shows six images, posted on "September 20, 2025" and "October 1, 2025".[18] All six are a "Report of Analysis" from one laboratory, Chromate, for client Tex Peptides. Each sample was received on 11 September 2025 and tested by reversed-phase HPLC with UV detection.
| Report | Product, batch | Found | Purity |
|---|---|---|---|
| #27790[19] | Retatrutide 10mg, RT-10-0001-TP | 10.87 mg | 99.181% |
| #27791[9] | Retatrutide 20mg, RT-20-0001-TP | 21.88 mg | 99.658% |
| #27792[20] | Tirzepatide 15mg, TZ-15-0001-TP | 15.19 mg | 99.435% |
| #27793[21] | Tirzepatide 30mg, TZ-30-0001-TP | 34.56 mg | 99.809% |
| #27904[22] | BPC-157 10mg, BC-10-0001-TP | 9.728 mg | 99.831% |
| #27905[23] | TB-500 (17-23) 10mg, TB-10-0001-TP | 9.583 mg | 99.908% |

Figure 3. Chromate's September 2025 report on a 20 mg retatrutide vial: 21.88 mg found, about 9% over the label. The method is HPLC with a UV detector; there is no mass spectrum. The vial in the photo is labelled RETRATRUTIDE.[9]
Four of the six find more than the label. The largest gap is the 30 mg tirzepatide vial, at 34.56 mg, 15% over.[21] A vial with more than its label says is still a dosing error for anyone who measures by the label. The BPC-157 and TB-500 vials come in 3% and 4% under.[22][23]
The vials photographed on both retatrutide reports are labelled RETRATRUTIDE, misspelled.[19][9] The product photo on the store spells it correctly.[11]

Figure 4. The 10 mg report from the same week: 10.87 mg, 99.181%. The store's own copy and the copy on the laboratory's portal are the same file, byte for byte.[19]
What the reports do and do not show. The method is HPLC with a UV detector, which measures how much of the sample elutes as one peak. It does not weigh the molecule, as mass spectrometry would. Chromate's site says "All tests are qualitative and quantitative analyses by HPLC unless otherwise specified." and lists a retatrutide test at "Retatrutide $300".[24] Its site says "Our lab is based within the US" and claims no accreditation.[24] Each report prints an access code for Chromate's verification portal. On 18 November 2026 we looked up all six: the portal serves the same image files the store posted, byte for byte.[25]
What is not covered. The About page promises "comprehensive lab reports available for every product".[2] The store publishes reports for four of its 34 products. There is none for semaglutide, SS-31, tesamorelin or PT-141, and none for any batch after September 2025. We have no independent test of a Tex Peptides product.
Regulatory and legal
FDA warning letter, 24 August 2026. The FDA's Center for Drug Evaluation and Research wrote to TXP Innovations LLC by email. Violations were found "during a review of your website texpeptide.com in July 2026". The letter lists "Semaglutide (GLP-1 SEM)", "Tirzepatide (GLP-2 TRZ)", "Retatrutide (GLP-3 RT)", "SS-31 (Elamipretide)", Tesamorelin, "PT-141 (Bremelanotide)" and "Bacteriostatic Water 0.9% Benzyl Alcohol (10 ml)", and says they "are unapproved new drugs under section 505(a)" of the Federal Food, Drug, and Cosmetic Act.[6]
The letter quotes the July product pages. The retatrutide page said: "GLP-3 RT offers a unique and comprehensive approach to regulating glucose metabolism, energy balance, and weight management." The semaglutide page said: "This makes GLP-1 SEM a key area of interest in the management of type 2 diabetes, obesity, and metabolic disorders." The PT-141 page promised to "improve libido and pleasure".[6]
On the research-use labels, the FDA wrote that "evidence obtained from your website establishes that your products are intended to be drugs for human use", and that selling bacteriostatic water as a solvent for the peptides meant "providing the means to prepare an injectable drug for human administration". It asked for a written response within "fifteen (15) business days".[6] On 18 November 2026 the FDA's index showed no response letter and no close-out letter for this firm.[26]
What changed after the letter. By 20 September 2026 the claims were gone. Each product page now says only that the product "will arrive in a lyophilized (powder) form for maximum stability".[12] Bacteriostatic water was no longer in the catalogue; "Acetic Water 0.6% Acetic Acid (3ml)" was, under "Reconstitution Solutions".[10]
The products stayed. On 20 September all six peptides the letter named were listed.[10] "GLP-3 RT (20mg)" was "In stock" at the address the letter quotes, as were the 30 mg tirzepatide and the tesamorelin.[12][16][27] The 10 mg semaglutide was "Out of stock".[15] On 18 November the retatrutide page was still "In stock".[11] The tracker of retatrutide sellers lists Tex Peptides among the FDA's 2026 letter recipients still selling the product.
Research use only. The home page says "FOR RESEARCH AND LABORATORY USE ONLY" and "NOT FOR HUMAN OR VETERINARY USE". The footer says the company does not operate as a compounding pharmacy, "nor as an outsourcing facility under 503B" of the Act.[1]
Age. The site opens with a box asking whether the visitor is over 21 "years of age", with Yes and No buttons and a "Remember me" option.[1] It is a click-through.
Lawsuits. We found no suit against TXP Innovations LLC. The Lilly case often confused with it is against Texas Peptides Inc., covered above.
Still open
- Who runs it. The FDA names the chief executive. The Comptroller's record gives the company's file number but not its organizer or registered agent, and we did not read the Secretary of State's filing.
- Where it ships from. The site gives a post-office box in Orange, the state a private mailbox in Dallas. We found no premises.
- What buyers got. We found no buyer's report in five subreddits' archives, so delivery and quality are unknown.
- Payment. The archived pages include no payment or refund policy, so payment is unknown.
- The retatrutide pages' chemistry. The site gives BPC-157's formula for retatrutide. The certificates name retatrutide and test by HPLC alone. Neither settles what is in a vial.
Changes
2026-11-18: first published.
References
- texpeptide.com home page, archived 2026-09-20 — Wayback Machine
- texpeptide.com, About, archived 2026-09-20 — Wayback Machine
- texpeptide.com, contact page, archived 2026-09-20 — Wayback Machine
- Texas Comptroller of Public Accounts, active franchise-tax permit holders (open data), record for TXP INNOVATIONS LLC, read 2026-11-18 — Texas Comptroller of Public Accounts, via data.texas.gov
- RDAP record for texpeptide.com (registered 2025-08-11, registrar Network Solutions, last changed 2026-07-13), read 2026-11-18 — Verisign
- FDA warning letter to TXP Innovations LLC dba Tex Peptides, MARCS-CMS 735067, 2026-08-24 — U.S. Food and Drug Administration
- Eli Lilly and Company v. Texas Peptides Inc., No. 5:26-cv-05146 (W.D. Tex.), complaint (ECF 1), filed 2026-08-12 — US District Court, W.D. Tex., via CourtListener RECAP
- Docket, Eli Lilly and Company v. Texas Peptides Inc., 5:26-cv-05146 (W.D. Tex.): notice of voluntary dismissal with prejudice, 2026-10-15 — CourtListener (RECAP)
- Chromate Report of Analysis #27791, Retatrutide 20mg, batch RT-20-0001-TP, produced 2025-09-16, as published by the store (archived 2026-09-20) — Wayback Machine
- texpeptide.com, shop, archived 2026-09-20 — Wayback Machine
- texpeptide.com, product page GLP-3 RT (20mg), captured 2026-11-18 — Wayback Machine
- texpeptide.com, product page GLP-3 RT (20mg), archived 2026-09-20 — Wayback Machine
- BPC-157 (CID 9941957): molecular formula C62H98N16O22, molecular weight 1419.5 g/mol, synonyms Bepecin and PLD-116, CAS 137525-51-0 — PubChem
- texpeptide.com, product page GLP-3 RT (10mg), archived 2026-10-30 — Wayback Machine
- texpeptide.com, product page GLP-1 SEM (10mg), archived 2026-09-20 — Wayback Machine
- texpeptide.com, product page GLP-2 TRZ (30mg), archived 2026-09-20 — Wayback Machine
- r/Peptides (18,427 posts since 2025-09-01), r/Retatrutide (20,000 since 2026-06-07), r/moreplatesmoredates, r/sarmssourcetalk and r/fitness, through the Arctic Shift archive, searched for 'Tex Peptides', 'texpeptide', 'TXP' and 'Texas peptides' on 2026-11-18: no thread names the store — Arctic Shift — anecdotal report, not evidence
- texpeptide.com, COA's, archived 2026-09-20 — Wayback Machine
- Chromate Report of Analysis #27790, Retatrutide 10mg, batch RT-10-0001-TP, produced 2025-09-16, as published by the store (archived 2026-09-20) — Wayback Machine
- Chromate Report of Analysis #27792, Tirzepatide 15mg, batch TZ-15-0001-TP, produced 2025-09-16, as published by the store (archived 2026-09-20) — Wayback Machine
- Chromate Report of Analysis #27793, Tirzepatide 30mg, batch TZ-30-0001-TP, produced 2025-09-16, as published by the store (archived 2026-09-20) — Wayback Machine
- Chromate Report of Analysis #27904, BPC-157 10mg, batch BC-10-0001-TP, produced 2025-09-20, as published by the store (archived 2026-09-20) — Wayback Machine
- Chromate Report of Analysis #27905, TB-500 (17-23) 10mg, batch TB-10-0001-TP, produced 2025-09-20, as published by the store (archived 2026-09-20) — Wayback Machine
- Chromate, Services and prices (read 2026-11-18) — Chromate
- Chromate's verification portal, report #27791 (one of six looked up on 2026-11-18; each image the portal serves is byte-identical to the store's copy) — Chromate
- FDA warning-letter index searched 2026-11-18 for 'retatrutide': the Response Letter and Closeout Letter columns are empty for the Tex Peptides letter — U.S. Food and Drug Administration
- texpeptide.com, product page Tesamorelin (10mg), archived 2026-09-20 — Wayback Machine
Comments
Sign in to join the conversation.
No comments yet.